Giảm thiểu tình trạng teo cơ vân trong chứng suy mòn ung thư nhờ d-myo-inositol 1,2,6-triphosphate

Beck SA, Tisdale MJ (1989) Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice. Cancer Res 49:3800–3804 Belizario JE, Lorite MJ, Tisdale MJ (2001) Cleavage of caspases-1,-3,6,-8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia. Br J Cancer 84:1135–1140 Bell D, McDermott BJ (1998) D-Myo inositol 1, 2, 6 triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) receptors or selective inhibitor of phosphatidylinositol cell signaling? Gen Pharmacol 31:689–696 Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Baulerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD (2001) Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3:1014–1019 Brink M, Price SR, Chrast J, Bailey JL, Anwar A, Mitch WE, Delafontaine P (2001) Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinol 142:1489–1496 Cariuk P, Lorite MJ, Todorov PT, Field WN, Wigmore SJ, Tisdale MJ (1997) Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients. Br J Cancer 76:606–613 Carlberg U, Nilsson A, Nygard O (1990) Functional properties of phosphorylated elongation factor 2. Eur J Biochem 191:639–645 Chan CP, McNall SJ, Krebs EG, Fischer EH (1988) Stimulation of protein phosphatase activity by insulin and growth factors in 3T3 cells. Proc Natl Acad Sci USA 85:6257–6261 Chang RC, Suen KC, Ma CH, Elvaman W, Ng HK, Hugon J (2002) Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor 2-alpha in neuronal degeneration. J Neurochem 83:1215–1225 Claxson A, Morris C, Blake D, Siren M, Halliwell B, Gustafsson T, Lofkvist B, Bergelin I (1990) The anti-inflammatory effects of D-myo-inositol-1, 2, 6-triphosphate (PP56) on animal models of inflammation. Agents Actions 29:68–70 Du J, Wang X, Miereles C, Bailey JL, Bailey JL, Debigare R, Zheng B, Price SR, Mitch WE (2004) Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 113:115–123 Eley HL, Russell ST, Tisdale MJ (2007) Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase. Br J Cancer 96:1216–1222 Eley HL, Russell ST, Tisdale MJ (2007) Effect of branched chain-amino acids on muscle atrophy in cancer cachexia. Biochem J 407:113–120 Eley HL, Skipworth RJE, Deans DAC, Fearon KCH, Tisdale MJ (2008) Increased expression of phosphorylated forms of RNA-dependent protein kinase (PKR) and eukaryotic initiation factor 2α (eIF2α) may signal skeletal muscle atrophy in weight losing cancer patients. Br J Cancer 98:443–449 Eley HL, Tisdale MJ (2007) Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation. J Biol Chem 282:7087–7097 Emery PW, Edwards RHT, Rennie MJ, Souhami RL, Halliday D (1984) Protein synthesis in muscle measured in vivo in cachectic patients with cancer. Br Med J 289:584–588 Fearon KCH (1992) The mechanisms and treatment of weight loss in cancer. Proc Nutr Soc 51:251–265 Felemez M, Speiss B (2001) Investigation of the ternary D-myo-inositol 1, 2, 6-tris (phosphate)-spermine-Zn2+ system in solution. J Inorg Biochem 84:107–111 Hershfinkel M, Moran A, Grossman N, Sekler I (2001) A zinc-sensing receptor triggers the release of intracellular Ca2+ and regulates ion transport. Proc Natl Acad Sci USA 98:11749–11754 Hovland R, Eikom TS, Proud CG, Cressey LI, Lanotte M, Doskeland SO, Houge G (1999) cAMP inhibits translation by inducing Ca2+/calmodulin-independent elongation factor 2 kinase activity in IPC-81 cells. FEBS Lett 444:97–101 Khal J, Hine AV, Fearon KCH, Dejong CHC, Tisdale MJ (2005) Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss. Int J Biochem Cell Biol 37:2196–2206 Kimball SR, Jefferson LS (2006) Signaling pathways and molecular mechanism through which branched-chain amino acids mediate translational control of protein synthesis. J Nutr 136:227S–231S Kumar A, Haque J, Lacoste J, Hiscott J, Williams BRG (1994) Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc Natl Acad Sci USA 91:6288–6292 Larsson S, Karlberg I, Selin E, Daneryd P, Pterson H-I (1987) Trace element changes in serum and skeletal muscle compared to tumour tissue in sarcoma-bearing rats. In Vivo 1:131–140 Loprinzi CL, Schaid DJ, Dose AM, Burnham NL, Jensen MD (1993) Body composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 11:152–154 O’Keefe SJD, Ogden J, Ramjee G, Rund J (1990) Contribution of elevated protein turnover and anorexia to cachexia in patients with hepatocellular carcinoma. Cancer Res 50:1226–1231 Orino E, Tanaka K, Tamura T, Sone S, Ogura T, Ichihara A (1991) ATP-dependent reversible association of proteasomes with multiple protein components to form 26S complexes that degrade ubiquitinated proteins in human HL-60 cells. FEBS Lett 258:7928–7934 Panniers R, Henshaw EC (1983) A GDP/GTP exchange factor essential for eukaryotic initiation factor 2 cycling in Ehrlich ascites tumor cells and its regulation by eukaryotic initiation factor 2 phosphorylation. J Biol Chem 258:7928–7934 Proud CG (2007) Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem J 403:217–234 Russell ST, Zimmerman TP, Domin BA, Tisdale MJ (2004) Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein. Biochem Biophys Acta 1636:59–68 Smith HJ, Greenberg NA, Tisdale MJ (2004) Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice. Br J Cancer 91:408–412 Smith HJ, Mukherji P, Tisdale MJ (2005) Attenuation of proteasome-induced proteolysis in skeletal muscle by β-hydroxy-β-methylbutyrate in cancer-induced muscle loss. Cancer Res 65:277–283 Suen K-C, Yu M-S, So K-F, Chang RC-C, Hugon J (2003) Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in β-amyloid peptide neurotoxicity. J Biol Chem 278:49819–49827 Tan S-L, Tareen SU, Melville MW, Blakely CM, Katze MG (2002) The direct binding of the catalytic subunit of protein phosphatase 1 to the PKR protein kinase is necessary but not sufficient for inactivation and disruption of enzyme dimer formation. J Biol Chem 277:36109–36117 Tisdale MJ (2002) Cachexia in cancer patients. Nat Rev Cancer 2:862–871 Todorov PT, McDevitt TM, Cariuk P, Coles B, Deacon M, Tisdale MJ (1996) Induction of muscle protein degradation and weight loss by a tumor product. Cancer Res 56:1256–1261 Whitehouse AS, Smith HJ, Drake JL, Tisdale MJ (2001) Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid. Cancer Res 61:3604–3609